Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease
Seladin-1 may mediate estrogen's neuroprotective effects
May 5th, 2005
Seladin-1 may mediate estrogen's neuroprotective effects, suggest study findings. The observation that Alzheimer's disease is more common in postmenopausal women has led to the suggestion that estrogen therapy may be beneficial. This proposition is supported by experimental studies, mostly in animals, that demonstrated estrogen's neuroprotective effects, researchers said. S. Benvenuti and colleagues, University of Florence, reported, "We previously established neuroblast long-term cell cultures from human fetal olfactory epithelium. In the present study, we addressed the role of estrogen in these unique human cells, which express both the estrogen...
Source: Women's Health Weekly (2005-05-05)
|
